Liquidia LQDA
NASDAQ LQDA
$68.47 +0.79 (+1.17%)
As of: Sep 9, 2026 · 2:29 PM EDT

Liquidia (LQDA) Net Income (2020 - 2026)

Liquidia (LQDA) posted Net Income of $74.7 million for Q2 2026, up 41.31% on a QoQ basis from $52.9 million in Q1 2026, and up 279.65% year-over-year from $19.7 million in Q2 2025.

Analysis

Liquidia (LQDA) Net Income (2020 - 2026) Analysis & Trends

Liquidia has reported Net Income for 7 years, with the latest figure at $74.7 million in Q2 2026.

  • On a quarterly basis, Net Income rose 279.65% year-over-year to $74.7 million in Q2 2026; TTM through Jun 2026 was $138.6 million, a 192.71% increase from a year earlier, with the FY2025 full-year figure at -$68.9 million, up 46.28% from the prior year.
  • Net Income was $74.7 million for Q2 2026 at Liquidia, up from $52.9 million in the prior quarter.
  • The five-year high for Net Income was $74.7 million in Q2 2026, with the low at -$41.6 million in Q2 2025.
  • Average Net Income over 5 years is -$10.3 million, with a median of -$15.4 million recorded in 2022.
  • The sharpest annual moves came in 2023 and 2026: Net Income sank 320.17% in 2023, then jumped 279.65% in 2026.
  • Over 5 years, Net Income stood at -$6.5 million in 2022, then tumbled by 320.17% to -$27.4 million in 2023, then slumped by 40.29% to -$38.5 million in 2024, then surged by 137.8% to $14.6 million in 2025, then soared by 413.21% to $74.7 million in 2026.
  • The last three Net Income figures came in at $74.7 million (Q2 2026), $52.9 million (Q1 2026), and $14.6 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Johnson & Johnson 646.53 Bn 625.77 Bn 17.26 Bn 5.53 Bn
2 AbbVie 442.27 Bn 435.70 Bn 12.70 Bn 3.62 Bn
3 Merck 366.81 Bn 359.67 Bn 12.21 Bn -1.34 Bn
4 Novartis Ag 266.82 Bn 259.13 Bn 11.24 Bn 5.28 Bn
5 Pfizer 159.37 Bn 147.67 Bn 10.94 Bn -238.00 Mn
6 Sanofi 52.46 Bn 45.08 Bn 10.79 Bn 2.16 Bn
7 Revolution Medicines 44.12 Bn 44.12 Bn - -644.37 Mn
8 Incyte 25.49 Bn 20.95 Bn 1.57 Bn 585.61 Mn
9 United Therapeutics 21.55 Bn 18.89 Bn 683.80 Mn 333.00 Mn
10 Liquidia 6.09 Bn 5.80 Bn 160.92 Mn 74.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 74.70 Mn
Mar 31, 2026 52.86 Mn
Dec 31, 2025 14.56 Mn
Sep 30, 2025 -3.53 Mn
Jun 30, 2025 -41.58 Mn
Mar 31, 2025 -38.37 Mn
Dec 31, 2024 -38.51 Mn
Sep 30, 2024 -31.03 Mn
Jun 30, 2024 -28.67 Mn
Mar 31, 2024 -30.08 Mn
Dec 31, 2023 -27.45 Mn
Sep 30, 2023 -15.79 Mn
Jun 30, 2023 -23.52 Mn
Mar 31, 2023 -9.43 Mn
Dec 31, 2022 -6.53 Mn
Sep 30, 2022 -9.09 Mn
Jun 30, 2022 -9.45 Mn
Mar 31, 2022 -14.95 Mn
Dec 31, 2021 -11.56 Mn
Sep 30, 2021 -7.28 Mn